Nature of Precipitation Resulted from Intravenous Drugs Incompatibility

Suci Hanifah(1), Patrick A. Ball(2), Ross A. Kennedy(3),


(1) Universitas Islam Indonesia
(2) University of Wolverhampton
(3) Charles Sturt University
Corresponding Author

Abstract


In critical care, the co-administration of intravenous drugs often leads to physical incompatibilities, resulting in harmful precipitates. This study evaluated the nature of drug-induced precipitation in terms of size, shape, and quantity. Twelve drugs previously reported to be incompatible were tested with infusion fluids. Particle detection was conducted using an Olympus CX41 microscope with a 1 µm detection limit, enhanced by darkfield microscopy for better sensitivity. Particle size was analyzed using Feret’s diameter via the Optilab imaging system. Precipitates ranged from 5–150 µm, with smaller particles (<10 µm) seen in furosemide and subvisible particles (10–50 µm) in cefotaxime, chloramphenicol, and paracetamol. Visible particles were noted in acyclovir, ampicillin, meropenem, phenobarbital, and phenytoin. Most macro-precipitates were acicular, while micro-precipitates tended to be irregular. Particle counts ranged from 80 to 2,000 particles/mL. The findings highlight the clinical risk of particulate contamination due to drug incompatibilities, emphasizing the need for careful medication management.

Keywords


Incompatibility; Intravenous; Macro-precipitates; Micro-precipitates; Particulate matter

References


Benlabed, M., Perez, M., Gaudy, R., Genay, S., Lannoy, D., Barthelemy, C., and Decaudin, B. (2019). Clinical implications of intravenous drug incompatibilities in critically ill patients. Anaesthesia Critical Care & Pain Medicine, 38(2), 173-180.

Christensen, M. L., Zareie, P., Kadiyala, B., Bursac, Z., Reed, M. D., Mattison, D. R., and Davis, R. L. (2021). Concomitant ceftriaxone and intravenous calcium therapy in infants. The Journal of Pediatric Pharmacology and Therapeutics, 26(7), 702-707.

Doessegger, L., Mahler, H. C., Szczesny, P., Rockstroh, H., Kallmeyer, G., Langenkamp, A., and Famulare, J. (2012). The potential clinical relevance of visible particles in parenteral drugs. Journal of Pharmaceutical Sciences, 101(8), 2635-2644.

Febres-Aldana, C. A., and Howard, L. H. (2018). Fatal Sickling Triggered by Massive Foreign Particle Embolism: A Case Report of Unrecognized Indwelling Venous Catheter Drug Abuse in Sickle Cell Disease. The American Journal of Forensic Medicine and Pathology, 39(2), 152-156.

Hanifah, S., Ball, P., and Kennedy, R. (2018). Medication incompatibility in intravenous lines in a Paediatric Intensive Care Unit (PICU) of Indonesian hospital. Critical Care & Shock, 21(3), 114-123.

Hanifah, S., Maulidani, Y., Nugroho, B. H., and Sari, C. P. (2019). All-in-one versus lipid-free parenteral nutrition for premature infants: visual, pH, and particle size analyses. Nutricion Hospitalaria, 36(6), 1-4.

Hanifah, S., Maulidani, Y., Nugroho, B. H., and Sari, C. P. (2021). Provision of standardized all-in-one parenteral nutrition (AIO-PN) for very preterm neonates: Evaluation at room and cold temperatures. Journal of Pharmacy and Bioallied Sciences, 13(1), 26-30.

Hanifah, S., Nugroho, B., and Chabib, L. (2020). Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection. Anaesthesiology Intensive Therapy, 52(1), 23-27.

Hantrakool, S., Kumfu, S., Chattipakorn, S. C., AND Chattipakorn, N. (2022). Effects of particulate matter on inflammation and thrombosis: past evidence for future prevention. International Journal of Environmental Research and Public Health, 19(14), 8771.

Jack, T., Brent, B. E., Boehne, M., Müller, M., Sewald, K., Braun, A., Wessel, A., and Sasse, M. (2010). Analysis of particulate contaminations of infusion solutions in a pediatric intensive care unit. Intensive Care Medicine, 36, 707-711.

Koller, A. K., Krebs, S., and Dörje, F. (2020). Medication safety in intravenous therapy: a compatibility study of clonidine with drugs frequently used in intensive care. Pharmaceutics, 13(1), 21.

Langille, S. E. (2013). Particulate matter in injectable drug products. PDA Journal Pharmaceutical Science and Technology, 67(3), 186-200.

Licina, D., Bhangar, S., Brooks, B., Baker, R., Firek, B., Tang, X., and Nazaroff, W. W. (2016). Concentrations and sources of airborne particles in a neonatal intensive care unit. PloS One, 11(5), e0154991.

Liu, F., and Hutchinson, R. (2024). Visible particles in parenteral drug products: A review of current safety assessment practice. Current Research in Toxicology, 7, 100175.

Marsilio, N. R., Silva, D. D., and Bueno, D. (2016). Drug incompatibilities in the adult intensive care unit of a university hospital. Revista Brasileira de Terapia Intensiva, 28, 147-153.

Molina, S. A., Davies, S. J., Sethi, D., Oh, S., Durand, N., Scott, M., and Clarke, D. (2022). Particulates are everywhere, but are they harmful in cell and gene therapies?. Cytotherapy, 24(12), 1195-1200.

Négrier, L., Martin Mena, A., Lebuffe, G., Odou, P., Genay, S., and Décaudin, B. (2021). Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review. European Journal of Clinical Pharmacology, 77, 1309-1321.

van den Hoogen, A., Krediet, T. G., Uiterwaal, C. S., Bolenius, J. F., Gerards, L. J., and Fleer, A. (2006). In-line filters in central venous catheters in a neonatal intensive care unit. Journal of Perinatal Medicine, 34(1), 71-74.

Veggeland, T., AND Brandl, M. (2010). Evaluation of a simple method for visual detection of microprecipitates in blends of parenteral drug solutions using a focused (Tyndall) light beam. International Journal of Pharmaceutical Compounding, 14(1), 78-81.

Worthington, P., Gura, K. M., Kraft, M. D., Nishikawa, R., Guenter, P., Sacks, G. S., and Committee, A. P. S. (2021). Update on the use of filters for parenteral nutrition: an ASPEN position paper. Nutrition in Clinical Practice, 36(1), 29-39.


Full Text: PDF

Article Metrics

Abstract View : 99 times
PDF Download : 105 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Bumi Publikasi Nusantara

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.